The Problem of Hospital Readmissions

Reducing hospital readmission rates has become a priority to policymakers because readmissions are common, costly and (at least in theory) a reasonable fraction of them should be preventable. Policymakers therefore believe that reducing readmission rates represents a unique opportunity to simultaneously improve quality of care and reduce costs. As part of the Affordable Care Act (ACA), Congress directed the Centers for Medicare and Medicaid Services (CMS) to penalize hospitals with "worse than expected" 30-day readmission rates. This part of the ACA has motivated hospitals, health systems, professional societies and independent organizations to invest substantial resources into finding and implementing solutions for the "readmissions problem".

Avixena provides unique Readmission Risk Assessment Survey tools which were developed after reviewing more than 60,000 inpatient Medicare FFS, Medicare Advantage, D-SNP, and Managed Medicaid admissions.

The cost of a single readmission to a hospital averages $13,000. Avixena easily pays for itself by avoiding a single readmission.

The scoring methodology and analysis was based on review of 7,000 readmissions. These apps are the most advanced assessment tool in their class with >90% specificity and >90% sensitivity. The apps have a scoring system, and also allow for automatic generation of options (such as a discharge plan). In addition, these apps incorporate and quantify the effect of social determinant of health (availability of transportation, housing or social support system) or type of health insurance on readmissions. The cost of a single readmission to a hospital averages $13,000. Avixena pays for itself by avoiding a single readmission.